课题基金 / 基金详情

Regulation of HIV-1 Preintegration Complexes (PICs)

Regulation of HIV-1 Preintegration Complexes (PICs)
HIV-1 预整合复合物 (PIC) 的调控
批准号:
6496397
负责人:
Richard Syd Kornbluth
金额:
$24.62万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2004-09-29

项目摘要

项目成果

Richard Syd Kornbluth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Unlike reverse transcriptase and protease, HIV integrase is difficult to study as an isolated enzyme because it functions in vivo in the context of the preintegration complex (PIC), a particle composed of both viral and host cell-derived components. In resting CD4+ T cells, this complex was found to be in an inactive form termed a ?pro-preintegration complex? or ?pro-PIC,? which is hypothesized to be the physical embodiment of preintegration latency. Cell stimulation is needed to convert the pro-PIC to an integration-competent PIC. Little is known about the molecular nature of the conversion process, and the exact composition of the PIC remains unknown. This project will address these issues from two opposite faces of the problem: on the host?s side, where immunological processes occur which trigger the formation of the active PIC; and on the virus?s side, where molecular changes convert the pro-PIC into the PIC. The four specific aims are: (1) To characterize the cellular stimuli that affect PIC activity in CD4+ T cells and macrophages; (2) To develop purification methods for pro-PICs and PICs from cells infected in vitro and to use them to establish the existence of pro-PICs and PICs in vivo in samples taken from HIV-infected individuals; (3) To define the structure and composition of pro-PICs and PICs using DNA footprinting, antibodies, and mass spectrometry; and (4) To screen PICs with a library of reactive compounds to find a putative new category of integration inhibitors which block PIC activity without directly inhibiting integrase. Taken together, these studies will clarify the linkage between the immunological processes that stimulate HIV replication and the molecular changes that they effect upon pro-PICs and PICs. New tools and concepts will be gained, and precise molecular targets for anti-HIV drug design will come into focus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MagaVax vaccine for Ebola
  • 批准号:
    9254569
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2016
  • 负责人:
    Richard Syd Kornbluth
  • 依托单位:
Ovarian cancer therapy using CD40 Ligand (CD40L)
  • 批准号:
    8648384
  • 项目类别:
  • 资助金额:
    $22.39万
  • 财政年份:
    2014
  • 负责人:
    Richard Syd Kornbluth
  • 依托单位:
Development of a multimeric CD40 ligand vaccine adjuvant
  • 批准号:
    8456940
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2013
  • 负责人:
    Richard Syd Kornbluth
  • 依托单位:
Development of a multimeric CD40 ligand vaccine adjuvant
  • 批准号:
    8715683
  • 项目类别:
  • 资助金额:
    $29.34万
  • 财政年份:
    2013
  • 负责人:
    Richard Syd Kornbluth
  • 依托单位:
海外基金